Stay updated on Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.3.3 is now displayed in the footer. The HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed.
    Difference
    0.1%
    Check dated 2025-12-23T13:31:16.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Publication notes were updated to state that publications are automatically filled from PubMed and may not always pertain to the study, replacing the previous longer description. The page revision tag was updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-24T17:54:45.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A notice about potential data delays due to government funding lapses and the NIH Clinical Center's operating status was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:46:15.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Results from KEYNOTE-040 are now displayed, including OS, PFS, ORR, DOR, and safety outcomes. The new content provides outcome data for pembrolizumab versus standard treatment in recurrent/metastatic head and neck cancer.
    Difference
    0.4%
    Check dated 2025-11-03T12:35:05.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    2%
    Check dated 2025-10-05T17:31:48.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Update the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.
    Difference
    0.0%
    Check dated 2025-09-28T10:38:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Treatment in Head and Neck Cancer Clinical Trial page.